Key result
The abstract describes a study to validate the clinical value of ABI and PWV in chronic hemodialysis patients, but reports no quantitative results.
Why the study?
Does assessment by ABI and baPWV have clinical value for evaluating arterial damage in chronic hemodialysis patients?
Observational
Does assessment by ABI and baPWV have clinical value for evaluating arterial damage in chronic hemodialysis patients?
This study aims to validate the clinical utility of ABI and baPWV for assessing arterial damage and its association with cardiovascular risk factors in chronic hemodialysis patients.
Answers are grounded in this paper and cite their sources.
No quantitative results reported; leaves open the clinical value of ABI and baPWV in hemodialysis patients.
Cardiovascular disease (CVD) is the leading cause of mortality and morbidity among patients with ESRD on chronic dialysis. Arterial damage is one of the characteristics of CVD. But the association between arterial damage and conventional risk factors for CVD has not yet been fully highlighted in chronic hemodialysis patients. Here we validate the clinical value of assessment of arterial damage by ABI and PWV in chronic hemodialysis patients in Macau.
No takes yet. Share an insight, caveat, or question.
Li et al. (2014) conducted an observational in End-stage renal disease on chronic hemodialysis. Conventional risk factors for cardiovascular disease was evaluated on Arterial damage assessed by ankle-brachial index (ABI) and brachial-ankle pulse wave velocity (baPWV). The abstract describes a study to validate the clinical value of ABI and PWV in chronic hemodialysis patients, but reports no quantitative results.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: